Fourth-Generation HIV Assays and False-Negative Results Beyond the 45-Day Window Period
A definitive published count of fourth-generation HIV laboratory false-negative results occurring after the commonly cited 45-day window period in real (non-panel) individuals has not been identified in the available literature. [1], [2], [3]
Window Period Used for Interpretation of Fourth-Generation Testing
CDC guidance states that a laboratory antigen/antibody test using blood from a vein “can usually detect HIV 18 to 45 days after exposure.” [1]
Evidence Base for Late False-Negatives in Real Individuals
Published studies documenting fourth-generation assay “false negatives” frequently involve either (a) seroconversion specimens or (b) blinded acute-infection panels, which do not provide a real-world denominator tied to a specific post-exposure day 46-or-later assessment in identifiable individuals. [4]
Documented Late Detection Problems During Seroconversion
A recognized phenomenon is a “second diagnostic window,” in which a fourth-generation immunoassay can become nonreactive after antigen levels fall and before antibody levels rise. [3]
Reports Involving Prolonged Diagnostic Windows
A case report described an HIV-1 primary infection with a prolonged diagnostic window on a fourth-generation immunoassay in which detection would have been missed by some algorithms that assume earlier reactivity. [3]
Quantification After Day 45
Because the available sources describe either guideline window-period ranges or non-individual specimen/panel performance, and because case reports of prolonged diagnostic windows have described delays that extend beyond expected detection without providing a systematic tally specifically after day 45 in real individuals, the number of false negatives reported after the 45-day window period cannot be quantified from the cited evidence. [1], [3], [4]